Complex injectable are designed to infuse drug through a hollow needle and a syringe which is penetrated through the skin into the body. Complex injectable market is gaining traction in the injectable therapies/infusion treatment owing to increase in use in life-threatening and chronic diseases treatments. The manufacturing of the complex injectable products is extremely complex and requires major investment. Since the injectables are highly toxic and infectious in nature, therefore a great level observation of quality and care is required during their manufacturing, packaging, distribution and storage.
Market for complex injectable is primarily driven by the rising incidence of chronic diseases, increase in the demand for self-injection devices, technological advancements challenges, stability of the product when combined with other products, growth of biologics market, preference of other modes of drug delivery. Increase number of needle-stick infections is the restraint for the injectable market.
The global Complex Injectable market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Complex Injectable volume and value at global level, regional level and company level. From a global perspective, this report represents overall Complex Injectable market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Eli Lilly
Pfizer
Teva Pharmaceutical Industries
Hospira
Hikma Pharmaceutical
Johnson & Johnson Pharmaceutical
Novo Nordisk
Abbvie
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Bottles
Vials
Ampules
Cartridges
Segment by Application
Hospitals And Clinics
Home Care Settings
Online Pharmacies
Others
Table of Contents
Executive Summary
1 Complex Injectable Market Overview
1.1 Product Overview and Scope of Complex Injectable
1.2 Complex Injectable Segment by Type
1.2.1 Global Complex Injectable Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Bottles
1.2.3 Vials
1.2.4 Ampules
1.2.5 Cartridges
1.3 Complex Injectable Segment by Application
1.3.1 Complex Injectable Consumption Comparison by Application (2014-2025)
1.3.2 Hospitals And Clinics
1.3.3 Home Care Settings
1.3.4 Online Pharmacies
1.3.5 Others
1.4 Global Complex Injectable Market by Region
1.4.1 Global Complex Injectable Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global Complex Injectable Market Size
1.5.1 Global Complex Injectable Revenue (2014-2025)
1.5.2 Global Complex Injectable Production (2014-2025)
2 Global Complex Injectable Market Competition by Manufacturers
2.1 Global Complex Injectable Production Market Share by Manufacturers (2014-2019)
2.2 Global Complex Injectable Revenue Share by Manufacturers (2014-2019)
2.3 Global Complex Injectable Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Complex Injectable Production Sites, Area Served, Product Types
2.5 Complex Injectable Market Competitive Situation and Trends
Summary: Get latest Market Research Reports on Complex Injectable. Industry analysis & Market Report on Complex Injectable is a syndicated market report, published as Global Complex Injectable Market Research Report 2019. It is complete Research Study and Industry Analysis of Complex Injectable market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.